We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$801M
AUM Growth
+$49.2M
Cap. Flow
+$6.75M
Cap. Flow %
0.84%
Top 10 Hldgs %
6.03%
Holding
1,189
New
181
Increased
356
Reduced
307
Closed
240

Top Sells

Rank Stock Value
1
TNET icon
TriNet
TNET
+$2.62M
2
QCOM icon
Qualcomm
QCOM
+$2.16M
3
TMO icon
Thermo Fisher Scientific
TMO
+$2.12M
4
XEC
CIMAREX ENERGY CO
XEC
+$2.1M
5
CRI icon
Carter's
CRI
+$2.07M

Sector Composition

Rank Sector Weight
1 Technology 19.44%
2 Industrials 14.79%
3 Healthcare 13.13%
4 Consumer Discretionary 12.63%
5 Financials 12.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
876
Seres Therapeutics
MCRB
$49.5M
$171K 0.02%
1,024
+131
+15% +$20.8K
AGEN
877
Agenus
AGEN
$256M
$169K 0.02%
2,679
+1,170
+78% +$92.3K
HOPE icon
878
Hope Bancorp
HOPE
$1.71B
$168K 0.02%
11,419
-700
-6% -$10.3K
NWBI icon
879
Northwest Bancshares
NWBI
$2.23B
$168K 0.02%
11,864
RVI
880
DELISTED
Retail Value Inc. Common Shares
RVI
$167K 0.02%
+53,281
New +$151K
DBRG icon
881
DigitalBridge
DBRG
$2.92B
$164K 0.02%
4,934
-6,258
-56% -$186K
SCPL
882
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$162K 0.02%
+11,750
New +$211K
CBAY
883
DELISTED
Cymabay Therapeutics
CBAY
$159K 0.02%
47,134
+25,450
+117% +$96.6K
GNW icon
884
Genworth Financial
GNW
$3.8B
$157K 0.02%
38,834
MRSN
885
DELISTED
Mersana Therapeutics
MRSN
$156K 0.02%
1,004
+288
+40% +$56K
NXTC icon
886
NextCure
NXTC
$17.3M
$156K 0.02%
2,160
+336
+18% +$28.1K
REAL icon
887
The RealReal
REAL
$1.36B
$156K 0.02%
13,458
-6,839
-34% -$89.9K
SYRE icon
888
Spyre Therapeutics
SYRE
$8.64B
$154K 0.02%
1,297
-175
-12% -$27.6K
MRAM icon
889
Everspin Technologies
MRAM
$387M
$151K 0.02%
13,370
+2,780
+26% +$25.2K
CSTE icon
890
Caesarstone
CSTE
$75.7M
$150K 0.02%
13,238
+730
+6% +$8.75K
EGAN icon
891
eGain
EGAN
$173M
$145K 0.02%
14,575
-35,372
-71% -$367K
HBP
892
DELISTED
Huttig Building Products, Inc.
HBP
$145K 0.02%
+13,091
New +$106K
EAR
893
DELISTED
Eargo, Inc. Common Stock
EAR
$144K 0.02%
+1,409
New +$183K
INO icon
894
Inovio Pharmaceuticals
INO
$86.4M
$138K 0.02%
2,299
+1,225
+114% +$98.1K
EPZM
895
DELISTED
Epizyme, Inc
EPZM
$136K 0.02%
+54,360
New +$214K
EGY icon
896
Vaalco Energy
EGY
$607M
$131K 0.02%
+40,930
New +$136K
OI icon
897
O-I Glass
OI
$1.37B
$131K 0.02%
+10,900
New +$138K
AXGN icon
898
Axogen
AXGN
$2.09B
$130K 0.02%
+13,828
New +$166K
LADR
899
Ladder Capital
LADR
$1.21B
$129K 0.02%
+10,737
New +$127K
TCRR
900
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$129K 0.02%
27,596
-24,584
-47% -$154K

Similar funds

Algert Global's Q4 2021 Portfolio in Review

As of Q4 2021, Algert Global held 1,189 positions worth $801M, up 6.5% from $751M the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Algert Global's Q4 2021 filing shows 181 new, 356 increased, 307 reduced and 240 closed positions. Its largest new stake was Owens Corning: 21,543 shares worth $1.95M. The largest sale was TriNet, an estimated $2.62M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Algert Global's largest Q4 2021 buy was Owens Corning: 21,543 shares worth $1.95M.
  • Algert Global added most to Alphabet (Google) Class A in Q4 2021, an estimated $2.2M increase.
  • Algert Global's biggest Q4 2021 reduction was TriNet, cutting an estimated $2.62M.
  • Algert Global fully exited Thermo Fisher Scientific in Q4 2021, selling an estimated $2.12M.
  • Algert Global's ten largest holdings make up 6% of its $801M portfolio in Q4 2021.
  • Algert Global opened 181 new positions and closed 240 in Q4 2021.
  • Algert Global's portfolio value rose 6.5% quarter-over-quarter to $801M.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.